http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
주민참여형 농어촌 테마공원 개발계획 연구 : 청풍지구 농어촌 테마공원을 중심으로
박용순,윤영근,제상호,손경석 경기대학교 부설 관광종합연구소 2014 여가관광연구 Vol.21 No.-
Rural theme park is an on-going business that has been practiced by Ministry for Food, Agriculture,Forestry and Fisheries since 2007. The business aimed to facilitate urban and rural interchange and local economy activation. Rural theme park themed communities by using unique natural and cultural properties owned by the locals. the project adopts bottom-up development that reflects opinions of residents in the tourism planning process. However, it seems to be true that residents have been excluded from tourism planning process even if they were the host of the project for the reasons of lack of knowledge on community-based rural tourism development and lack of experience on bottom-up development. The case of Chung Poong Area in Je Cheon rural theme park used in this study has prioritize residents' involvement in planning procedure. This project emphasized the importance of residents' participation and their role in the entire process of tourism development that ranges from project site decision to the major business decision. Thus, this study suggests a direction that can be used for the future rural theme park projects and community-based project related to planning and design in rural area. 농어촌 테마공원(Rura1 Theme Park) 사업은 2007년부터 농림수산식품부에서 지속적으로 증가하고 있는 농촌관광 수요를 충족하고 농촌지역의 활성화를 위해 진행하고 있는 사업으로 도농교류 및 지역경제 활성화를 목적으로 하고 있다. 농어촌 테마공원은 농촌지역이 가지고 있는 고유한 자연적,문화적 자원 등을 주제로 지역특색에 맞게끔 다양한 형태의 테마공원을 조성하는 것으로 지역주민의 의견을 적극적으로 수렴하는 상향식 사업으로 진행해 나아가고 있다. 그럼에도 불구하고 사업의 실질적인 주체인 지역주민의 경우 주민참여형 농환지역개발사업에 대한 이해부족과 상향식 사업에 대한 경험부족 등으로 계획수립 과정에서 소외되고 있는 것 또한 현실이다. 본 연구는 제천지구 농어촌 테마공원 기본계획을 수립하는 과정에서 지역주민의 참여를 우선적으로 고려하였으며,대상지 선정에서부터 주요사업 도출과정에 이르기까지 계획수립의 전과정에서 걸쳐서 지역주민의 참여와 역할에 대해서 언급하고 있다. 따라서 향후 농어촌테마공원뿐만 아니라 농어촌지역계획 수립과 관련한 주민참여형 사업에 기초자료로 활용될 수 있는 방안을 제시하고자 한다.
중추 신경계를 침범한 전신성 홍반성 낭창의 임상적 연구
정윤석,박석원,이돈행,김시찬,박중원,홍천수 대한내과학회 1992 대한내과학회지 Vol.42 No.1
1987년 7월부터 1990년 6월까지 연세의대 세브란스 병원에 입원한 전신성 흉반성 낭창 환자 103예를 대상으로 조사하여 신경학적 증상과 징후가 있거나 뇌 전산화 단층 촬영상 또는 뇌파 검사상 이상이 있는 경우, 또는 정신병적 증상과 징후가 나타난 경우를 중추 신경계 낭창이라고 정의하였을때 다음과 같은 결과를 얻었다. 1) 전체 103예중 43예(41.7%)에서 중추 신경계 침범을 보였다. 2) 중추 신경계 낭창군은 비 중추 신경계 낭창군에 비하여 높은 초기 사망률을 나타내었다. 3) 중추 신경계 낭창군은 비 중추 신경계 낭창군에 비하여 신장 기능이 의의 있게 저하되어 있었다. 4) 중추 신경계 낭창군과 비 중추 신경계 낭창군 사이에 유병기간, 침범된 장기, 자가면역 항체 등에 있어서는 유의한 차이를 보이지 않았다. 결론적으로 전신성 홍반성 낭창환자, 특히 신장 기능이 저하되어 있는 환자는 중추 신경계 침범 여부를 조심스럽게 관찰하여 조기에 진단하고, 중추 신경계 침범이 확인된 경우는 사망률을 저하시키기 위하여 보다 적극적인 치료를 요할 것으로 사료된다. Central nervous system involvement in systemic lupus erythematosus (CNS lupus) is characterized by difficulty in it's proper diagnosis, treatment, and poor prognosis. We analyzed 103 systemic lupus erythematosus patients who have admitted to Severance Hospital, Yonsei University, from July 1987 to June 1990. The results were as followed: 1) 43 cases out of 103 systemic lupus erythematosus patients had central nervous system involvement. 2) Immediate mortality in CNS lupus was significantly higher than non-CNS lupus group. 3) Renal functions in CNS lupus were more significantly impaired than non-CNS lupus group. 4) There was no significant difference in duration of disease, number of organ involved, autoantibodies between CNS and non-CNS lupus group. These results suggest that patients with imparied renal function should be carefully followed up for early detection of central nervous system involvement. And, if central nervous system involvement is suspected, then more aggressive treatment may be required to reduce high mortality rate.
골다공증 환자에서 Alendronate (Marvil)의 1년간 치료효과
김효정,박지원,이수진,이관우,김현만,정윤석 대한내분비학회 2003 Endocrinology and metabolism Vol.18 No.1
연구배경: Alendronate는 골흡수 억제작용을 가진 비스포스포네이트 제재 중 하나로 골다공증의 치료와 예방에 사용되고 있으며 골밀도를 증가시키고 골다공증으로 인한 골절의 빈도를 감소시킨다고 보고되고 있다. 방법: 본 연구는 alendronate(Marvil??)가 골다공증의 치료에 미치는 효과를 검증하기 위하여 138명의 골다공증 진단을 받은 환자를 대상으로 시작하였고 1년 후 50명에서 골대사지표와 골밀도를 추적관찰하였다. 결과: Alendronate를 1년간 투여하였을 때 혈청 ALP는 38.3% 감소하였고 요중 DPD는 40.5% 감소하였다. Alendronate를 1년간 투여하였을 때 L2-4의 평균 골밀도는 6.7% 증가하였고 대퇴골의 평균 골밀도는 20.% 증가하였다. 4명(8%)에서 1년 이내에 새로운 골절이 발생하였고 이 중 3명은 척추골절, 1명은 대퇴골절이었다. 부작용으로 투약을 중단한 환자는 8명(5.8%)이었고 이 중 7명(5.1%)이 소화기증상을 호소하였다. 결론: 이상의 결과로 골다공증 환자에서 alendronate(Marvil??)의 1년간 투여가 골밀도를 증가시킴을 알 수 있었다. Background: To evaluate the effects of alendronate in preventing bone loss at the spine and hip in Korean cases of primary osteoporosis, we treated 138 patients with 10㎎ of alendronate daily. Of the 138 patients treated, 50 were treated for one complete year, and at their final visit, measurements were taken to assess the completed outcome of reatment, and the results from this small group were compared with those of the rest. The way this has been written causes ambiguity concerning exactly who was being studied. Check that my rewrite of this section conveys correctly the group that was studied, and how. Methods: The serum levels of calcium(Ca) and phosphorous(P), total alkaline phosphatase(ALP), the urine calcium creatinine ratio(Uca/cr) and urine deoxypyridinoline(DPD) were measured before, during, and after the 1 year treatment period. The bone mineral densities(BMDs) at the spine and hip were also measured before and after the treatment period. New clinical fractures and side effects, were evaluated during the treatment period. Results: The total serum ALP and urine DPD were decreased significantly, after the treatment period, by 38.3 and 40.5% respectively. The bone mineral density at the spine and hip were significantly increase after 1 year, by 6.7 and 2.0%, respectively. Of the 50 subjects who had completed a full year of treatment, only 4(8%) had developed new clinical fractures. Of the 138 patients who had been treated, 8(5.7%) discontinued the medication due to side effects. Of these, 7 had gastrointestinal symptoms, and 1 had skin eruption. Conclusion: Alendronate significantly decreased the total serum ALP and urine DPD and significantly increase spine and hip bone mineral density. Alendronate 10㎎ was effective in preventing bone loss in Korean cases of primary osteoporosis (J Kor Soc Endocrinol 18:56∼62, 2003)
Effect of Residual Lithium Rearrangement on Ni-rich Layered Oxide Cathodes for Lithium-Ion Batteries
Park, Jun-Ho,Choi, Byungjin,Kang, Yoon-Sok,Park, Seong Yong,Yun, Dong Jin,Park, Insun,Shim, Jae Ha,Park, Jin-Hwan,Han, Heung Nam,Park, Kwangjin Wiley (John WileySons) 2018 Energy technology Vol.6 No.7
Chung, Yoon-Sok,Lim, Sung-Kil,Chung, Ho-Yeon,Lee, In-Kyu,Park, Il-Hyung,Kim, Ghi-Su,Min, Yong-Ki,Kang, Moo-Il,Chung, Dong-Jin,Kim, Yong-Ki,Choi, Woong Hwan,Shong, Min Ho,Park, Ji-Hyun,Byun, Dong-Won,Y Springer-Verlag 2009 Calcified tissue international Vol.85 No.5
<P>Patient preferences, convenience, and bone turnover markers were evaluated for the monthly ibandronate over the weekly risedronate regimen in Korean postmenopausal osteoporotic women. This was a 6-month, prospective, randomized, open-label, multicenter study with a two-period and two-sequence crossover treatment design. After a 30-day screening period, eligible participants with postmenopausal osteoporosis were randomized to receive either monthly oral ibandronate 150 mg for 3 months followed by weekly oral risedronate 35 mg for 12 weeks (sequence A) or the same regimen in reverse order (sequence B). Patient preference and convenience were evaluated by questionnaire. The changes in serum C-telopeptide after 3 months of treatment were analyzed. A total of 365 patients were enrolled in this study (sequence A 182, sequence B 183). Of patients expressing a preference (83.4%), 74.8% preferred the monthly ibandronate regimen over the weekly regimen (25.2%). More women stated that the monthly ibandronate regimen was more convenient (84.2%) than the weekly regimen (15.8%). There was no significant difference in the change in bone turnover marker between the two treatments. The two regimens were similarly tolerable. There were fewer adverse events in the monthly ibandronate group compared to the weekly risedronate group in terms of gastrointestinal side effects (nausea and abdominal distension). This study revealed a strong preference and convenience for monthly ibandronate over weekly risedronate in Korean postmenopausal osteoporotic women. There was no significant difference in change of bone turnover marker and safety profile between the two regimens.</P>
정윤석(Yoon Sok Chung),김현만(Hyeon Man Kim),이은직(Eun Jig Lee),정재희(Jae Hee Chung),이경미(Kyung Mi Lee),박석원(Seog Won Park),조홍근(Hong Keun Cho),이현철(Hyun Chul Lee),허갑범(Kap Bum Huh),박유경(Yoo Kyoung Park),김희선(Hee Son 대한내과학회 1994 대한내과학회지 Vol.47 No.3
N/A Objectives: Growth hormone secretory capacity of adults decrease with aging, Growth hormone secretory capacity and prevalence of growth hormone deficiency in Korean adults were studied. Methods: History, physical examination, and routine blood tests were performed to roule out ill patients among ordinary subjects. Anthropometry, nutritional history, serum insulin-like growth factor-1 (IGF-1) levels, L-dopa stimulation tests, and urinary growth hormone levels were measured in 309 Korean adults, ages 20-87 years. Results: The mean serum IGF-1 levels were 258,2+6. 8 ng/ml. The mean serum IGF-1 levels of adult males were significantly higher than those of the females. The serum IGF-1 levels decreased with aging. The prevalence of growth hormone deficiency defined by serum IGF-1 levels (< 150 ng/ml) were 0.0% in the 3rd decade, 5.5% in the 4th decade, 12.2% in the 5th decade, 10.0% in the 6th decade, 32.1% in the 7th decade, 48.1% in the 8th decade, respectively. The serum IGF-1 levels were positively correlated with total energy expenditure, but negatively correlated with body fat mass. The peak serum growth hormone levels after L-dopa stimulation and urinary growth hormone levels of the younger subjects were significantly higher than those of the older subjects, There were goad correlations among serum IGF-1 levels, peak growth hormone levels after L-dopa stimulation, and urinary growth hormone levels. Conclusion: Growth hormone secretory capacity decreased significantly with aging, and growth hormone deficiency was found in about 1/3 of subjects aged over 60 years.
Lee, Byoung-Sun,Yoon, Jihyun,Jung, Changhoon,Kim, Dong Young,Jeon, Seung-Yeol,Kim, Ki-Hong,Park, Jun-Ho,Park, Hosang,Lee, Kang Hee,Kang, Yoon-Sok,Park, Jin-Hwan,Jung, Heechul,Yu, Woong-Ryeol,Doo, Seok American Chemical Society 2016 ACS NANO Vol.10 No.2
<P>We report on the synergetic effects of silicon (Si) and BaTiO3 (BTO) for applications as the anode of Li-ion batteries. The large expansion of Si during lithiation was exploited as an energy source via piezoelectric BTO nanoparticles. Si and BTO nanoparticles were dispersed in a matrix consisting of multiwalled carbon nanotubes (CNTs) using a high-energy ball-milling process. The mechanical stress resulting from the expansion of Si was transferred via the CNT matrix to the BTO, which can be poled, so that a piezoelectric potential is generated. We found that this local piezoelectric potential can improve the electrochemical performance of the Si/CNT/BTO nanocomposite anodes. Experimental measurements and simulation results support the increased mobility of Li-ions due to the local piezoelectric potential.</P>